World Health Organization

Apply to be a member of the WHO Civil Society Task Force on TB: Call for expressions of interest from the WHO Region of the Americas

The World Health Organization (WHO) Global TB Program is the Secretariat of the WHO Civil Society Task Force on TB. The aim of the Task Force is to intensify the voice of civil society in ending TB at all levels.

Read More →

WHO Information Note: Ensuring continuity of TB services during the COVID-19 pandemic

20 March 2020 | GENEVA: As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that essential health services and operations are continued to protect the lives of people with TB and other diseases or health conditions. Health services, including national programmes to combat TB, need to be actively engaged in ensuring an effective and rapid response to COVID-19 while ensuring that TB services are maintained.

Read More →

World TB Day 2020: It's Time To End TB!

WHO advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.

Read More →

WHO announces forthcoming changes for the programmatic management of TB preventive treatment

The World Health Organization issues a Rapid Communication announcing a number of updates to its latest guidance on TB preventive treatment.

Read More →

Executive Board supports WHO progress report on the End TB Strategy and recommends adoption of a Global Strategy for TB Research and Innovation

07 February 2020 | GENEVA - Member States during the 146th session of the World Health Organization (WHO) Executive Board, reviewed a  progress report on the implementation of the End TB Strategy and put forward a resolution to the World Health Assembly adopting a new global strategy for tuberculosis (TB) research and innovation.

Read More →

WHO FAQs on key changes to the treatment of drug-resistant TB

The World Health Organization (WHO) Global TB Program, in close collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, the United States Agency for International Development (USAID) and the Global Drug Facility of the Stop TB Partnership have updated the Frequently Asked Questions (FAQs) document on WHO’s Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis.

Read More →

Lack of new antibiotics threatens global efforts to contain drug-resistant infections

Two new reports of the World Health Organization reveal a weak pipeline for antibiotic agents.

Read More →

WHO announces updates on new molecular assays for the diagnosis of TB and drug resistance

13 January 2020 | GENEVA - Significant improvements to the diagnosis of tuberculosis (TB) and rifampicin resistance in adults and children are expected, following key updates on new molecular assays, announced by the World Health Organization (WHO) in a Rapid Communication released today.

Read More →

WHO Global TB Program: 2019 progress review

The World Health Organization (WHO) Global TB Program released a newsletter highlighting the overall progress in the global TB response in 2019. The Global TB Report 2019 is now available in app form.

Read More →

WHO announces changes to the treatment of drug-resistant TB

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

Read More →

Page 1 of 22 · Total posts: 10

1 2 Last→